Analysis of 13 Million Individual Patient Records Pertaining To Pap Smears, Colposcopies, Biopsies and Surgery on The Uterine Cervix (Belgium, 1996–2000)
Cervical cancer screening; Pap smear; Screening coverage; Colposcopy; Conization; Hysterectomy; Belgium
Abstract :
[en] Objective
Cervical cancer screening by surveys overestimate coverage because of selection and reporting biases.
Methods
The prepared Inter-Mutualistic Agency dataset has about 13 million records from Pap smears, colposcopies, cervical biopsies and surgery, performed in Belgium between 1996 and 2000. Cervical cancer screening coverage was defined as the proportion of the target population (women of 25–64 years) that has had a Pap smear taken within the last 3 years. Proportions and incidence rates were computed using official population data of the corresponding age group, area and calendar year.
Results
Cervical cancer screening coverage, in the period 1998–2000, was 59% at national level, for the target age group 25–64 years. Differences were small between the 3 regions. Variation ranged from 39% to 71%. Coverage was 64% for 25–29 year old women, 67% for those aged 30–39 years, 56% for those aged 50–54. The modal screening interval was 1 year. In the 3-year period 1998–2000, 3 million smears were taken from the 2.7 million women in the age group 25–64. Only 1.6 million women of the target group got one or more smears in that period and 1.1 million women had no smears, corresponding to an average of 1.88 smears per woman.
Conclusion
Coverage reached only 59%, but the number of smears used was sufficient to cover more than 100% of the target population. Structural reduction of overuse and extension of coverage is warranted.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Arbyn, Marc
Simoens, C.
Van Oyen, H.
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique - Labo de biologie des tumeurs et du développement
Goffin, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR
Simon, P.
Fabri, V.
Language :
English
Title :
Analysis of 13 Million Individual Patient Records Pertaining To Pap Smears, Colposcopies, Biopsies and Surgery on The Uterine Cervix (Belgium, 1996–2000)
Publication date :
2009
Journal title :
Preventive Medicine
ISSN :
0091-7435
eISSN :
1096-0260
Publisher :
Academic Press, New York, United States - New York
Anttila A., Ronco G., Lynge E., et al. Chapter 2: epidemiological guidelines for quality assurance in cervical cancer screening. In: Arbyn M., Anttila A., Jordan J., et al. (Eds). European Guidelines for Quality Assurance in Cervical Cancer Screening. 2nd ed (2008), Office for Official Publications of the European Communities, Luxembourg 11-52
Arbyn M., and Geys H. Trend of cervical cancer mortality in Belgium (1954-94): tentative solution for the certification problem of not specified uterine cancer. Int. J. Cancer 102 (2002) 649-654
Arbyn M., and Van Oyen H. Cervical cancer screening in Belgium. Eur. J. Cancer 36 (2000) 2191-2197
Arbyn M., and Van Oyen H. Analysis of individual health insurance data pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000) 21 (2004), Scientific Institute of Public Health, Brussels 1-102 IPH/EPI-REPORTS
Arbyn M., Albertyn G., and De Groof V. Consensus on follow-up recommendations in cervical cancer screening (in Dutch). Tijdschr voor Geneeskunde 52 (1996) 709-715
Arbyn M., Quataert P., Van Hal G., and Van Oyen H. Cervical cancer screening in the Flemish Region (Belgium): measurement of the attendance rate by telephone interview. Eur. J. Cancer Prev. 6 (1997) 389-398
Arbyn M., Bourgain C., Cuvelier C., et al. The Flemish Cervical Cancer Screening Register: creation and first results. Acta Cytol 43 (1999) 708-709
Arbyn M., Wallyn S., Van Oyen H., Nys H., Dhont J., and Seutin B. The new privacy law in Belgium: a legal basis for organised cancer screening. Eur. J. Health Law 6 (1999) 401-407
Arbyn M., Van Oyen H., Sartor F., Tibaldi F., and Molenberghs G. Description of the influence of age, period and cohort effects on cervical cancer mortality by loglinear Poisson models (Belgium, 1955-94). Arch. Public Health 60 (2002) 73-100
Arbyn M., Raifu A.O., Autier P., and Ferlay J. Burden of cervical cancer in Europe: estimates for 2004. Ann. Oncol. 18 (2007) 1708-1715
Arbyn M., Kyrgiou M., Simoens C., et al. Peri-natal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: a meta-analysis. BMJ 337 (2008) a1284
Arbyn, M., Annemans, L., Vandenbroecke, A., in press-a. Screening for cervical cancer in Belgium. Eur. J. Cancer.
Arbyn, M., Raifu, A.O., Bray, F., Weiderpass, E., Anttila, A., in press-b. Trends of cervical cancer mortality in the member states of the European Union. Eur. J. Cancer.
Arbyn M., Rebolj M., de Kok I.M., Becker N., O'Reilly M., Andrae B., in press-c. Challenges for organising cervical screening programmes in the 15 old member states of the European Union. Eur. J. Cancer.
Belgian Cancer Registry Foundation. Belgian Cancer Registry (2008)
Centre for Operational Research in Public Health. Standardised Procedures for Mortality Analysis (2006), Scientific Institute of Public Health, Brussels
Coleman D., Day N., Douglas G., et al. European guidelines for quality assurance in cervical cancer screening. Europe against cancer programme. Eur. J. Cancer 4 29A Suppl (1993) S1-S38
Commission of the European Communities, Proposal for a council recommendation on cancer screening. 2003/0093 (CNS), 1-22. Brussels, 5th of May 2003.
Council of the European Union. Council recommendation of 2 December 2003 on cancer screening. Off. J. Eur. Union 878 (2003) 34-38
Demarest S., Van der Heyden J., Gisle L., et al. Health Survey by Interview, Belgium 2001 25 (2002), Scientific Insitute of Public Health. IPH/EPI REPORTS, Brussels 1-2480
European Commission. European Guidelines for Quality Assurance in Cervical Cancer Screening, 2nd edn (2008), Office for Official Publications of the European Communities, Luxembourg
Fruchter R.G., Rones K., Roth T., Webber C.A., Camilien L., and Boyce J.G. Pap smear histories in a medical clinic: accuracy of patients' self-reports. N. Y. State J. Med. 92 (1992) 421-424
IARC. Cervix cancer screening. IARC Handbooks of Cancer Prevention. Vol. 10 (2005), Lyon, IARCPress
Jordan J., Martin-Hirsch P., Arbyn M., et al. In: Arbyn M., Anttila A., Jordan J., et al. (Eds). Chapter 6: management of abnormal cervical cytology. In: European Guidelines for Quality Assurance in Cervical Cancer Screening. 2nd edn (2008), Office for Official Publications of the European Communities, Luxembourg 191-232
Kleinbaum D.G., Kupper L.L., and Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods (1982), Van Nostrand Reinhold, New York
Kottke T.E., Trapp M.A., Fores M.M., et al. Cancer screening behaviors and attitudes of women in southeastern Minnesota. JAMA 273 (1995) 1099-1105
Kurman R.J., Henson D.E., Herbst A.L., Noller K.L., Schiffman M.H., and National Cancer Institute. Interim guidelines for management of abnormal cervical cytology. JAMA 271 (1994) 1866-1869
Kyrgiou M., Koliopoulos G., Martin-Hirsch P., Arbyn M., Prendiville W., and Paraskevaidis E. Obstetric outcomes after conservative treatment for intra-epithelial or early invasive cervical lesions: a systematic review and meta-analysis of the literature. Lancet 367 (2006) 489-498
Laara E., Day N.E., and Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1 (1987) 1247-1249
McKenna M.T., Speers M., Mallin K., and Warnecke R. Agreement between patient self-reports and medical records for Pap smear histories. Am. J. Prev. Med. 8 (1992) 287-291
Mertens R. Hysterectomie in België. Thematic Files of the CSF 1 (1999), National Alliance of the Christian Sickness Funds, Brussels 1-28
Miller A.B. The (in)efficiency of cervical screening in Europe. Eur. J. Cancer 38 (2002) 321-326
Montano D.E., and Phillips W.R. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am. J. Public Health 85 (1995) 795-800
Nygard J.F., Skare G.B., and Thoresen S.O. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. J. Med. Screen. 9 (2002) 86-91
Peto J., Gilham C., Fletcher O., and Matthews F.E. The cervical cancer epidemic that screening has prevented in the UK. Lancet 364 (2004) 249-256
Quinn M., Babb P., and Jones J. Effect of screening on incidence and mortality from cancer of the cervix in England: evaluation based on routinely collected statistics. BMJ 318 (1999) 904-908
Sirovich B.E., and Welch H.G. Cervical cancer screening among women without a cervix. JAMA 291 (2004) 2990-2993
van der Aa M.A., Schutter E.M., Looijen-Salamon M., Martens J.E., and Siesling S. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001. Eur. J. Obstet. Gynecol. Reprod. Biol. 139 (2007) 204-209
Walter S.D., Clarke E.A., Hatcher J., and Stitt L.W. A comparison of physician and patient reports of Pap smear histories. J. Clin. Epidemiol. 41 (1988) 401-410
Wright Jr. T.C., Massad L.S., Dunton C.J., Spitzer M., Wilkinson E.J., and Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am. J. Obstet. Gynecol. 197 (2007) 346-355